Immunotherapy and gene transfer in the treatment of the oncology patient: Role of transfusion medicine

Transfusion Medicine Reviews

Volumn 10, Issue 1, 1996, Pages 1-14

  Hillyer, C D ^a   Klein, H G ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CANCER; CANCER IMMUNOTHERAPY; CLINICAL PROTOCOL; GENE THERAPY; GENE TRANSFER; HUMAN; REVIEW;

EID: 0030035064     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(96)80118-0     Document Type: Article

References (111)

1. Kolb HJ Mittermuller J Clemm CH Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients Blood 76 1990 2462 2465
2. Cullis JO Jiang YZ Schwarer AP Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation Blood 79 1992 1379 1381
3. Porter DL Roth MS McGarigle C Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia N Engl J Med 330 1994 100 106
4. Miller AD Human gene therapy comes of age Nature 357 1992 455 460
5. Mathe G Transfusions et greffes de moelle osseuse homologue chez les humains irradies a hautes dose accidentellement Rev Fr Etudes Clin Biol 4 1959 238 240
6. van Bekkum DW de Vries JJ Radiation Chimeras 1967 Logos London, England 562 568
7. Bortin MM Horowitz MM Gale RP Current status of bone marrow transplantation in humans: Report from the International Bone Marrow Transplant Registry Nat Immun Cell Regul 7 1988 334 350
8. Hillyer CD Wells SJ Alternative sources of hematopoietic stem cells for bone marrow rescue and transplantation J Hematotherapy 2 1993 491 499
9. Treleaven JG Mehta J Bone marrow and peripheral blood stem cell harvesting J Hematotherapy 1 1992 215 223
10. Gianni AM Tarella C Sienca S Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells Bone Marrow Transplantation 6 1990 143 145
11. Haas R Ho AD Bredthauer U Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor Exp Hematol 18 1990 94 98
12. Kessinger A Armitage JO Smith DM High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma Blood 74 1989 1260 1265
13. Korbling M Przepiorka D Huh YO Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts Blood 85 1995 1659 1665
14. Bensinger WI Weaver CH Appelbaum FR Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor Blood 85 1995 1655 1658
15. Russell JA Luider J Weaver M Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors Bone Marrow Transplantation 15 1995 111 115
16. Goldman J Peripheral blood stem cells for allografting Blood 85 1995 1413 1415
17. Gale RP Champlin RE How does bone-marrow transplantation cure leukaemia Lancet 2 1984 28 30
18. Fefer A Sullivan KM Weiden P Graft versus leukemia effect in man: The relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation Truitt RL Gale RP Bortin MM Cellular Immunotherapy of Cancer 1987 Liss New York, NY 401 408
19. Weiden PL Flournoy N Thomas ED Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts N Engl J Med 300 1979 1068 1073
20. Goldman JM Gale RP Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk of relapse associated with T cell depletion Ann Intern Med 108 1988 806 814
21. Slavin S Ackerstein A Naperstek E The graft-versus-leukemia (GVL) phenomenon: Is GVL separable from GVHD? Bone Marrow Transplantation 6 1990 155 161
22. McCullough J Collection and use of stem cells: Role of transfusion centers in bone marrow transplantation Vox Sang 67 1994 35 42
23. Gee A Bone Marrowing Processing and Purging: A Practical Guide 1991 CRC Press Boca Raton, FL
24. Herve P Cahn JY Flexch M Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complement Blood 69 1987 388 393
25. Champlin R Ho W Gajewski J Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation Bone Marrow Transplantation 76 1990 418 423
26. Gross L Interdermal immunization of C3H mice against a sarcoma that originated in an animal of the same line Cancer Res 3 1943 326 328
27. Hellström I Hellström KE Pierce GE Cellular and humoral immunity to different types of human neoplasms Nature 220 1968 1352 1356
28. Grosser N Thomson DMP Tube leukocyte (monocyte) adherence inhibition assay for the detection of antitumor immunity. 3. “Blockage” of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients Int J Cancer 18 1976 58 62
29. Cornain S de Vries JE Collard J Antibodies and antigen expression in human melanoma detected by the immune adherence test Int J Cancer 16 1975 981 984
30. Herberman RB Oldham RK Problems associated with study of cell-mediated immunity to human tumors by microcytotoxicity assays J Natl Cancer Inst 55 1975 749 753
31. Fishbein GE Immunotherapy of lung cancer Sem Onc 20 1993 351 358
32. Mathe G Amiel JL Schwarzenberg L Active immunotherapy for acute lymphoblastic leukemia Lancet 2 1969 697 699
33. Topalian SL Rosenberg SA Tumor infiltrating lymphocytes. Evidence for specific immune reactions against growing cancers in mice and human De Vita VT Jr Hellman S Rosenberg SA Important Advances in Oncology 1990 Lippincott Philadelphia, PA 19 41
34. Levine P Bobbit OB Walker RK Isoimmunization by a new blood factor in tumor cells Proc Soc Exp Biol Med 77 1951 403 405
35. Moore G Sandberg A Amos DB Experimental and clinical adventures with large doses of gamma and other globulins as anticancer agents Surgery 41 1957 972 983
36. Sumner WC Foraker AG Spontaneous regression of human melanoma: Clinical and experimental studies Cancer 13 1960 79 81
37. Wright PW Hellstrom KE Hellstrom I Serotherapy of malignant disease Med Clin North Am 60 1976 607 611
38. Kohler G Milstein C Continuous culture of fused cells secreting antibodies of predefined specificity Nature 256 1975 495 497
39. Deland FH A perspective of monoclonal antibodies: Past, present, and future Semin Nucl Med 19 1989 158 165
40. Seemann G Bosslet K Sedlacek HH Recombinant monoclonal antibodies in tumor therapy Behring Institute Mitteilungen 87 1990 33 47
41. Wong JH Irie RF Morton DL Human monoclonal Semin Surg Oncol 5 1989 448 452
42. Goldenberg DM Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy Semin Nucl Med 19 1989 332 339
43. Landsteiner K Chase MW Experiments on transfer of cutaneous sensitivity to simple compounds Proc Soc Exp Biol Med 49 1942 688 690
44. Billingham RE Brent L Medawar PB Quantitative studies on tissue transplantation immunity. 2. The origin, strength, and duration of actively and adoptively acquired immunity Proc R Soc Lond [B] 143 1954 58 80
45. Kirkpatrick CH Rich RR Graw RG Characterization of a cellular immune defect in chronic mucocutaneous moniliasis J Allergy 45 1970 101 102
46. Morgan DA Ruscetti FW Gallo RC Selective in vitro growth of T lymphocytes from normal human bone marrows Science 193 1976 1007 1008
47. Lotze MT Matory YL Ettinghausen SE In vivo administration of purified human interleukin-2. 2. Half-life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL-2 J Immunol 135 1985 2865 2875
48. Kern DE Gillis S Okada M The role of interleukin-2 (IL-2) in the differentiation of cytotoxic T cells: The effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines J Immunol 127 1981 1323 1331
49. Bergman L The clinical significance of interleukin-2 Onkologie 13 1990 416 422
50. Chang AE Geiger JD Sondak VK Adoptive cellular therapy of malignancy Arch Surg 128 1993 1281 1290
51. Lafraniere R Rosenberg SA Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) can mediate the regression of both immunogeneic and non-immunogeneic sarcomas and an adenocarcinoma J Immunol 135 1985 4273 4280
52. Lotze MT Chang AE Seipp CA High-dose recombinant interleukin-2 in the treatment of patients with disseminated cancer JAMA 256 1986 3117 3124
53. Rosenberg SA Lotze MT Muul LM Observations on the systemic administration of autologous lymphokine activated killer cells and recombinant interleukin-2 to patients with metastatic cancer N Engl J Med 313 1985 1485 1492
54. Rosenberg SA Lotze MT Yang JC Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients Ann Surg 210 1989 474 485
55. Fisher RI Coltman CA Doroshow JH Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells: A phase II clinical trial Ann Intern Med 108 1988 518 523
56. Rosenberg SA Packard BS Aebersold PM Use of tumor infiltrating lymphocytes and interleukin 2 in the immunotherapy of patients with metastatic melanoma N Engl J Med 319 1988 1676 1680
57. Muul LM Spiess PJ Director EP Identification of specific cytolytic immune responses against autologous tumors in humans bearing malignant melanoma J Immunol 138 1987 989 995
58. Whiteside TL Heo DS Johnson JT Cytolytic effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2 Cancer Immunol Immunother 26 1988 1 10
59. Fisher B Packard BS Read EJ Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma J Clin Oncol 7 1989 250 261
60. Lotze MT Rosenberg SA Results of clinical trials with the administration of interleukin-2 and adoptive immunotherapy with activated cells in patients with cancer Immunobiology 172 1986 420 437
61. Eberlein TJ Schoof DD Jung S-E A new regimen of interleukin 2 and lymphokine-activated killer cells: Efficacy without significant toxicity Arch Intern Med 148 1988 2571 2576
62. Freedman RS Tomasovic B Templin S Largescale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy J Immunol Meth 167 1994 145 160
63. Andreesen R Hennemann B Adoptive immunotherapy with autologous macrophages: Current status and future perspectives Pathobiology 59 1991 259 263
64. Klein HG Adoptive immunotherapy: Normal applications of blood cell separators J Clin Apheresis 4 1988 198 202
65. Hamblin TJ Ex vivo activation and retransfusion of white blood cells Curr Stud Hematol Blood Trans 57 1990 249 266
66. Yanelli JR Thurman GB Dickenson SG An improved method for the generation of human lymphokine activated killer cells J Immunol Meth 108 1987 137 145
67. Bell AJ Wrightham M Stevenson FK Generation of lymphokine activated killer cells in a totally closed system Plasma Ther Transfus Technol 8 1987 371 376
68. Maal LM Nason-Burchenal K Carter C Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy J Immunol Meth 101 1987 171 181
69. Melder RJ Whiteside TL Vujanovic NL Human adherent lymphokine-activated killer (A-LAK) cells: A new approach to generating antitumour effects for adoptive immunotherapy Cancer Res 48 1988 3461 3469
70. Owen-Schaub LB Grimm EA Lymphokine-activated killer lymphocytes: Evidence for regulation of induction and function by multiple cytokine Stevenson HC Adoptive Cellular Immunotherapy of Cancer 1989 Dekker New York, NY 19 36
71. Kradin RL Lazarus DS Dubinett SM Tumor-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer Lancet i 1989 577 579
72. Treisman J Hwu P Minamoto S Interleukin-2 transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen Blood 85 1995 139 145
73. Stevens EJ Jacknin L Robbins PF Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated and allogeneic melanoma tumor cell lines: Fine specificity and MART-1 melanoma antigen recognition J Immunol 154 1995 62 71
74. Salgaller ML Weber JS Koenig S Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide Cancer Immunol Immunother 39 1994 105 116
75. Sporn JR Ergin MT Robbins GR Adoptive immunotherapy with peripheral blood lymphocytes cocultured in vitro with autologous tumor cells and interleukin-2 Cancer Immunology Immunotherapy 37 1993 175 180
76. Gold JE Malamud SC LeRosa F Adoptive chemoimmunotherapy for the treatment of relapsed and refractory solid tumors using ex vivo activated memory T cells (autolymphocyte therapy) and cyclophosphamide J Immunother 13 1993 213 221
77. Sawczuk IS Autolymphocyte therapy in the treatment of metastatic renal cell carcinoma Urol Clin North Am 20 1993 297 301
78. Drobyski WR Keever CA Roth MS Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: Efficacy and toxicity of a defined T-cell dose Blood 82 1993 2310 2318
79. Szer J Grigg AP Phillips GL Donor leukocyte infusions after chemotherapy for patients relapsing with acute leukemia following allogeneic BMT Bone Marrow Transplantation 11 1993 109 111
80. Sullivan KM Storb R Buckner CD Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms N Engl J Med 210 1989 828 834
81. Giralt S Esucdier S Kantarjian H Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation N Engl J Med 329 1993 757 761
82. Rosenberg SA Aebersold P Cornetta K Gene transfer into human-immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction N Engl J Med 323 1990 570 578
83. Toes RE Offringa R Feltkamp MJ Tumor rejection antigens and tumor specific cytotoxic T lymphocytes Behring Institute Mitteilungen 94 1994 72 86
84. Tepper RI Pattengale PK Leder P Murine interleukin-4 displays potent anti-tumor activity in vivo Cell 57 1989 503 512
85. Blaese RM Culver KW Progress toward the application of gene therapy Nance SJ Clinical and Basic Science Aspects of Immunohematology 1991 American Association of Blood Banks Arlington, VA 1 11
86. Tolstoshev P Gene therapy, concepts, current trials and future direction Annu Rev Pharmacol Toxicol 32 1993 573 596
87. Culver KW Ram Z Wallbridge S In vivo gene transfer with retroviral vector-producer cells for treat of experimental brain tumors Science 256 1992 1550 1552
88. Moritz T Williams DA Somatic gene therapy Anderson KC Ness PM Scientific Basis for Transfusion Medicine 1994 Saunders Philadelphia, PA
89. Mulligan RC The basic science of gene therapy Science 260 1993 926 932
90. Klein HG Cellular gene therapy: An overview J Clin Aphresis 9 1994 139 141
91. Miller AD Buttimore C Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production Mol Cell Biol 6 1986 2895 2902
92. Culver KW Anderson WF Blaese RM Lymphocyte gene therapy Hum Gene Ther 2 1991 107 109
93. Rosenberg SA Anderson WF Blaese M The development of gene therapy for the treatment of cancer Ann Surg 218 1993 455 464
94. Culver KW Blaese RM Gene therapy for cancer Trends Genet 10 1994 174 178
95. Geller AI Keyomarsi K Bryan J An efficient deletion mutant packaging system for detective herpes simplex virus vectors: Potential applications to human gene therapy and neuronal physiology Proc Natl Acad Sci USA 87 1990 8950 8954
96. (abstr) Chattergee S Wong KK Podsakoff G Adenoassociated virus vectors for high efficiency gene transfer into primary human hematopoietic cells Blood 80 1992 167a
97. Berkner KL Development of adenovirus vectors for the expression of heterologous genes BioTechniques 6 1988 616 628
98. Tiberghien P Use of suicide genes in gene therapy J Leukocyte Biol 56 1994 203 209
99. Kerr WG Mule JJ Gene therapy: Current status and future prospects J Leukocyte Biol 56 1994 210 214
100. Sorrentino BP Brandt SJ Bodine D Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1 Science 257 1992 99 103
101. Nabel GJ Nabel EG Yang ZY Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans Proc Natl Acad Sci USA 90 1993 11307 11311
102. Roth JA Modulation of oncogene and tumor-suppressor gene expression: A novel strategy for cancer prevention and treatment Ann Surg Oncol 1 1994 79 86
103. Fujiwara T Mukhopadhyay T Cai DW Retroviral-mediated transduction of P 53 gene increases TGF-beta expression in a human glioblastoma cell line Int J Cancer 56 1994 834 839
104. Lasky LC McCullough J Zanjani ED Liquid storage of unseparated human bone marrow: Evaluation of human progenitors by clonal assays Transfusion 31 1991 521 527
105. Cantin G Marchand-Laroche D Blood-derived stem cell collection in acute nonlymphoblastic leukemia: Predictive factors for a good yield Exp Hematol 17 1989 991 996
106. Branch DR Gallagher MT Forman ST Endogenous stem cell repopulation resulting in mixed hematopoietic chimerism following total body irradiation and marrow transplantation for acute leukemia Transplantation 34 1982 226 228
107. Oldfield E Ram Z Culver KW Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir Human Gene Ther 4 1993 39 69
108. Freeman S McCune C Angel C Treatment of ovarian cancer using HSV-TK gene modified vaccine and regulatory issues Human Gen Ther 3 1992 342 349
109. Lee J-H Klein HG Collection and use of peripheral hematopoietic progenitor cells Hematol Oncol Clin North Am 9 1995 1 22
110. McCullough J The role of the blood bank in transplantation Arch Pathol Lab Med 115 1991 1195 1200
111. Hillyer CD Emmens RK Zago-Novaretti M Reduction of transfusion-transmitted cytomegalovirus infection: Blood product manipulation versus use of seronegative donor units Transfusion 34 1994 929 934